Quest Diagnostics Q3 Adj. EPS $3.00 Beats $2.86 Estimate, Sales $3.097B Beat $3.046B Estimate
Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.86 by 4.9 percent. This is a 15.38 percent increase over earnings of $2.60 per share from the
Quest Diagnostics made more money than experts predicted this quarter. When a company beats its goals, it often means the business is running well and growing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.